Find out all you need to know about Ozempic and other weight loss drugs, including the dangers and side effects ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Drug manufacturer Novo Nordisk's amycretin, an experimental weight-loss pill in clinical trials, may boast substantial weight ...

An icon of a desk calendar. An icon of a circle with a diagonal line across. An icon of a block arrow pointing to the right. An icon of a paper envelope. An icon of the Facebook "f" mark. An icon ...

Prospect’s Alli Linke (23) drives toward the basket as the Knights play Maine South, Park Ridge, Illinois. | Allen Cunningham for Sun Times Allen Cunningham/For the Sun Times Share Prospect ...

A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...

An analyst thinks he has cracked the code on why highflying Eli Lilly missed two quarters of Wall Street projections.

Americans are split on using weight loss drugs such as Ozempic and Wegovy to treat obesity or weight-related conditions, according to a new survey that was published on Friday. The new ...

This article is part of a featured content programme.

It’s rare that technology circles back to old-school tools, but here we are using styluses to jot down notes on tablets. Of course, today’s versions swap ink and paper for pixels and precision. If you ...

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

First off, OMI is not a supplement, a term that implies a product will supplement for nutritional deficiencies that may contribute to hair loss. To be clear, poor nutrition—especially vitamin D, zinc, ...